Protagonist Therapeutics, Inc — Director's Dealing 2018

Jun 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Protagonist Therapeutics, Inc (PTGX)
CIK: 0001377121
Period of Report: 2018-05-31

Reporting Person: Saks Samuel R (Chief Development Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-31	Stock Option (right to buy)	$7.28	A	50000	Acquired	2028-05-30	Common Stock (50000)	Direct

Footnotes

F1: The option vests over a four-year period, with 1/4th of the shares subject to the option vesting on the one year anniversary of the vesting commencement date of May 21, 2018, and 1/36th of the remaining shares subject to the option vesting each month.